Berlin, New Jersey, USA

A Study of Psilocybin for Major Depressive Disorder (MDD)

Active, not recruiting
Depressive Disorder, Major
Start Date: Oct 2019
Last Updated: Apr 2022
New York, New York, USA / San Francisco, California, USA / Baltimore, Maryland, USA and 8 more
Psilocybin

A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Completed
Healthy Volunteer
Start Date: Sep 2018
Last Updated: Feb 2019
Long Beach, California, USA / Berlin, New Jersey, USA
Ketamine

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Completed
Healthy Volunteer
Start Date: Dec 2018
Last Updated: Jan 2022
Long Beach, California, USA / Berlin, New Jersey, USA
Ketamine

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Completed
Healthy Volunteer
Start Date: Nov 2018
Last Updated: Jan 2022
Long Beach, California, USA / Berlin, New Jersey, USA
Ketamine

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Completed
Depressive Disorder, Treatment-Resistant
Start Date: Feb 2019
Last Updated: Oct 2021
Atlanta, Georgia, USA / Oakland, California, USA / Rockville, Maryland, USA and 10 more
Ketamine

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Completed
Fibromyalgia
Start Date: Dec 2006
Last Updated: Jan 2012
London, England, United Kingdom / Chicago, Illinois, USA / Arlington, Virginia, USA and 101 more
GHB

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

Completed
Fibromyalgia
Start Date: Aug 2006
Last Updated: Dec 2011
Austin, Texas, USA / Houston, Texas, USA / Sacramento, California, USA and 60 more
GHB